Investigational knee injection targets cartilage loss in osteoarthritis patients
Keck Medicine of USC has launched a clinical trial testing the safety and tolerability of a new investigational treatment and its potential effects on preventing cartilage deterioration in people with knee osteoarthritis, the most common form of the disease.
Read original article on The Medical News →Related news
-
Q&A: AI can support mental health, but expert warns it should not replace qualified care
United Kingdom
-
Studies examine the connection between primary care provider resources and health outcomes for type 2 diabetes patients
United Kingdom
-
Local DNA motion remains nearly constant during cell interphase
United Kingdom
-
Higher childhood BMI associated with greater body dissatisfaction at age 14 in both boys and girls
United Kingdom
-
Indian diet shift exposes hidden genetic cholesterol risk
United Kingdom
-
Maternal vaccination helps protect newborns from deadly bacterial bloodstream infections, mouse study suggests
United Kingdom
-
Skin measurements show link between insomnia and disrupted fear responses
United Kingdom
-
What if mosquito saliva holds the key to better fighting Zika, dengue and West Nile viruses?
United Kingdom